JP2018528759A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528759A5 JP2018528759A5 JP2017567294A JP2017567294A JP2018528759A5 JP 2018528759 A5 JP2018528759 A5 JP 2018528759A5 JP 2017567294 A JP2017567294 A JP 2017567294A JP 2017567294 A JP2017567294 A JP 2017567294A JP 2018528759 A5 JP2018528759 A5 JP 2018528759A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cdr
- seq
- acid sequence
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187204P | 2015-06-30 | 2015-06-30 | |
| US62/187,204 | 2015-06-30 | ||
| PCT/US2016/040183 WO2017004254A1 (en) | 2015-06-30 | 2016-06-29 | Anti-vascular endothelial growth factor receptor 2 (vegfr2) antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018528759A JP2018528759A (ja) | 2018-10-04 |
| JP2018528759A5 true JP2018528759A5 (enExample) | 2019-08-08 |
Family
ID=57609558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017567294A Pending JP2018528759A (ja) | 2015-06-30 | 2016-06-29 | 抗血管内皮増殖因子受容体２（ｖｅｇｆｒ２）抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20180193456A1 (enExample) |
| EP (1) | EP3316908A4 (enExample) |
| JP (1) | JP2018528759A (enExample) |
| KR (1) | KR20180021136A (enExample) |
| CN (1) | CN108025067A (enExample) |
| AU (1) | AU2016288192A1 (enExample) |
| BR (1) | BR112017027702A2 (enExample) |
| CA (1) | CA2990450A1 (enExample) |
| HK (1) | HK1254048A1 (enExample) |
| RU (1) | RU2018103192A (enExample) |
| TW (1) | TW201718641A (enExample) |
| WO (1) | WO2017004254A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170233480A1 (en) | 2015-12-31 | 2017-08-17 | Development Center For Biotechnology | Anti-vegfr antibody and uses thereof |
| CN106674349B (zh) * | 2017-03-07 | 2018-03-13 | 北京东方百泰生物科技有限公司 | 一种改进的抗vegfr‑2单克隆抗体 |
| TWI665213B (zh) * | 2017-06-29 | 2019-07-11 | 財團法人生物技術開發中心 | 抗人類血管內皮生長因子受體之抗體及其應用 |
| JP7339325B2 (ja) * | 2018-03-20 | 2023-09-05 | ナショナル ヘルス リサーチ インスティテューツ | 単離抗体、医薬組成物、単離抗体結合体、ダイマー化阻害方法、シグナル伝達阻害方法、管新生阻害方法、治療方法、および断片検出方法 |
| WO2021013061A1 (zh) * | 2019-07-19 | 2021-01-28 | 神州细胞工程有限公司 | 一种人源化抗vegfr2抗体及其应用 |
| JP2024500847A (ja) | 2020-12-18 | 2024-01-10 | センチュリー セラピューティクス，インコーポレイテッド | 適合可能な受容体特異性を有するキメラ抗原受容体システム |
| CN113480653B (zh) * | 2021-08-06 | 2022-05-06 | 朱有建 | 一种含有γδT细胞的药物组合物在治疗癌症中的用途 |
| CN121449750A (zh) * | 2025-11-04 | 2026-02-03 | 上海以岭药业有限公司 | 一种双特异性抗体及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009013543A2 (en) * | 2007-07-25 | 2009-01-29 | Astrazeneca Ab | Targeted binging agents directed to kdr and uses thereof - 035 |
| HUE027358T2 (en) * | 2007-11-26 | 2016-09-28 | Bayer Ip Gmbh | Anti-mesothelin antibodies and their applications |
| US8128932B2 (en) * | 2009-08-17 | 2012-03-06 | Shanghai Aosaiersi Biotech Co., Ltd. | Anti-VEGFR monoclonal antibody, method of making and uses thereof |
| US9029510B2 (en) * | 2012-03-30 | 2015-05-12 | Sorrento Therapeutics, Inc. | Fully human antibodies that bind to VEGFR2 and methods of use thereof |
| CN116003600A (zh) * | 2012-10-05 | 2023-04-25 | 卡德门企业有限公司 | 人抗vegfr-2/kdr抗体 |
-
2016
- 2016-06-29 KR KR1020187002388A patent/KR20180021136A/ko not_active Withdrawn
- 2016-06-29 WO PCT/US2016/040183 patent/WO2017004254A1/en not_active Ceased
- 2016-06-29 JP JP2017567294A patent/JP2018528759A/ja active Pending
- 2016-06-29 HK HK18113110.8A patent/HK1254048A1/zh unknown
- 2016-06-29 CA CA2990450A patent/CA2990450A1/en not_active Abandoned
- 2016-06-29 TW TW105120598A patent/TW201718641A/zh unknown
- 2016-06-29 BR BR112017027702A patent/BR112017027702A2/pt not_active Application Discontinuation
- 2016-06-29 US US15/740,790 patent/US20180193456A1/en not_active Abandoned
- 2016-06-29 RU RU2018103192A patent/RU2018103192A/ru not_active Application Discontinuation
- 2016-06-29 CN CN201680049578.3A patent/CN108025067A/zh active Pending
- 2016-06-29 AU AU2016288192A patent/AU2016288192A1/en not_active Abandoned
- 2016-06-29 EP EP16818720.1A patent/EP3316908A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017521054A5 (enExample) | ||
| JP2020501598A5 (enExample) | ||
| JP2019535254A5 (ja) | 抗ｐｄ−ｌ１抗体および変異型 | |
| JP2021525546A5 (enExample) | ||
| CN118388647A (zh) | 一种分离的Claudin18.2抗体及其应用 | |
| JP2022542165A5 (enExample) | ||
| RU2017122014A (ru) | Антитела к c10orf54 и их применения | |
| JP2020534830A5 (enExample) | ||
| JP2017535257A5 (enExample) | ||
| US11970529B2 (en) | Protein binding to fibronectin B domain | |
| JP2013056885A5 (enExample) | ||
| JP7711208B2 (ja) | Ｄｌｌ３に対する結合分子及びその使用 | |
| JP2013502913A5 (enExample) | ||
| HRP20192038T1 (hr) | Protutijela receptora anti-epidermalnog faktora rasta (egfr) | |
| JP2011207882A5 (enExample) | ||
| RU2019107134A (ru) | Анти-pd-1 антитела | |
| RU2009123409A (ru) | Новые антипролиферативные антитела | |
| JP2013534515A5 (ja) | 受容体型チロシンキナーゼｃ−Ｍｅｔに対する抗体 | |
| JP2010509931A5 (enExample) | ||
| JP2020534012A5 (enExample) | ||
| JP2020522488A5 (enExample) | ||
| JP2022516848A (ja) | Ｂｔｎ３ａ結合タンパク質及びその使用 | |
| RU2018103192A (ru) | Антитела против рецептора 2 фактора роста эндотелия сосудов (vegfr2) | |
| JP2023549555A5 (enExample) | ||
| IL312060A (en) | Bispecific CD16A binders |